168 related articles for article (PubMed ID: 31201646)
1. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT
Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646
[TBL] [Abstract][Full Text] [Related]
2. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.
Heinhuis B; Plantinga TS; Semango G; Küsters B; Netea MG; Dinarello CA; Smit JWA; Netea-Maier RT; Joosten LAB
Carcinogenesis; 2016 Feb; 37(2):197-205. PubMed ID: 26678222
[TBL] [Abstract][Full Text] [Related]
3. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.
Heinhuis B; Koenders MI; van de Loo FA; Netea MG; van den Berg WB; Joosten LA
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4962-7. PubMed ID: 21383200
[TBL] [Abstract][Full Text] [Related]
4. A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.
Kang JW; Choi SC; Cho MC; Kim HJ; Kim JH; Lim JS; Kim SH; Han JY; Yoon DY
Immunology; 2009 Sep; 128(1 Suppl):e532-40. PubMed ID: 19740314
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.
Park JS; Choi SY; Lee JH; Lee M; Nam ES; Jeong AL; Lee S; Han S; Lee MS; Lim JS; Yoon DY; Kwon Y; Yang Y
Cell Oncol (Dordr); 2013 Dec; 36(6):493-503. PubMed ID: 24114327
[TBL] [Abstract][Full Text] [Related]
6. A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.
Plantinga TS; Costantini I; Heinhuis B; Huijbers A; Semango G; Kusters B; Netea MG; Hermus AR; Smit JW; Dinarello CA; Joosten LA; Netea-Maier RT
Carcinogenesis; 2013 Jul; 34(7):1529-35. PubMed ID: 23486016
[TBL] [Abstract][Full Text] [Related]
7. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.
Kobayashi H; Huang J; Ye F; Shyr Y; Blackwell TS; Lin PC
PLoS One; 2010 Mar; 5(3):e9458. PubMed ID: 20221440
[TBL] [Abstract][Full Text] [Related]
9. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.
Yun HM; Oh JH; Shim JH; Ban JO; Park KR; Kim JH; Lee DH; Kang JW; Park YH; Yu D; Kim Y; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2013 May; 4(5):e640. PubMed ID: 23703385
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production.
Kang JW; Park YS; Lee DH; Kim MS; Bak Y; Park SH; Ham SY; Yang Y; Hong JT; Yoon DY
FEBS Lett; 2013 Nov; 587(23):3776-81. PubMed ID: 24396867
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
14. Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8.
Numasaki M; Ito K; Takagi K; Nagashima K; Notsuda H; Ogino H; Ando R; Tomioka Y; Suzuki T; Okada Y; Nishioka Y; Unno M
Cell Immunol; 2023 Jan; 383():104652. PubMed ID: 36516653
[TBL] [Abstract][Full Text] [Related]
15. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
[TBL] [Abstract][Full Text] [Related]
16. Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells.
Hot A; Lenief V; Miossec P
Ann Rheum Dis; 2012 May; 71(5):768-76. PubMed ID: 22258491
[TBL] [Abstract][Full Text] [Related]
17. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition.
Zhang W; Gu J; Chen J; Zhang P; Ji R; Qian H; Xu W; Zhang X
Oncol Rep; 2017 Nov; 38(5):2959-2966. PubMed ID: 28901479
[TBL] [Abstract][Full Text] [Related]
18. Towards a role of interleukin-32 in atherosclerosis.
Heinhuis B; Popa CD; van Tits BL; Kim SH; Zeeuwen PL; van den Berg WB; van der Meer JW; van der Vliet JA; Stalenhoef AF; Dinarello CA; Netea MG; Joosten LA
Cytokine; 2013 Oct; 64(1):433-40. PubMed ID: 23727326
[TBL] [Abstract][Full Text] [Related]
19. Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cells.
Bai X; Kinney WH; Su WL; Bai A; Ovrutsky AR; Honda JR; Netea MG; Henao-Tamayo M; Ordway DJ; Dinarello CA; Chan ED
BMC Microbiol; 2015 Feb; 15():39. PubMed ID: 25887904
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced IL-32β increases glycolysis in breast cancer cells.
Park JS; Lee S; Jeong AL; Han S; Ka HI; Lim JS; Lee MS; Yoon DY; Lee JH; Yang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):800-8. PubMed ID: 25449783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
